Skip to content
Institutional LPInvests through funds, not into companiesLAST VERIFIED Oct 2026 · 4 SOURCES

Champalimaud Foundation

Also known as Fundação Champalimaud, Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud

Lisbon biomedical research foundation created in 2004 by António Champalimaud's will. Its €397.6M portfolio (2024) is invested mainly through external funds, with exposure to private equity funds.

Not to be confused with Grupo Manuel Champalimaud, the business group of Manuel Champalimaud.

HEADQUARTERS
Lisbon, Portugal
FOUNDED
2004
OUTSIDE CAPITAL
No — own capital only
TEAM LISTED
3 people

Focus

STAGES
—
SECTORS
—
ASSET MIX
Public equitiesPrivate equityHedge funds
GEOGRAPHY
—

Overview

The Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud) was created in 2004 by the will of António de Sommer Champalimaud and is a private foundation of public interest; it runs the Champalimaud Centre for the Unknown in Belém, Lisbon. Its financial assets had a market value of €397.6M at 31 December 2024 after a 12% return. The foundation describes its investment policy as generally passive, with top-down allocation by asset class and selection of the best funds in each category; alternative investments made up 46% of the portfolio and equities 20%, and it kept an exposure to private equity funds to strengthen long-term returns.

People

  • Leonor Beleza
    President · source
  • João Silveira Botelho
    Vice-President · source
  • António Horta Osório
    Board member · source

Links

Frequently asked questions

Champalimaud Foundation is a institutional investor based in Lisbon, Portugal, founded in 2004.

Champalimaud Foundation does not primarily put its own money into private companies. It also commits capital to third-party funds as an LP.

Key people at Champalimaud Foundation include Leonor Beleza (President), João Silveira Botelho (Vice-President) and António Horta Osório (Board member).

No. Champalimaud Foundation invests its own capital and does not raise money from outside investors.